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Glandular cardiac myxoma is rare, representing only 5% of cardiac myxomas. 
A 51-year-old female developed embolic events caused by left atrial myxoma. 
She underwent myxoma resection and had an uneventful postoperative course. 
Histology of the resected myxoma revealed a glandular cardiac myxoma. In this 
article, the peculiar case was presented and the origin of cardiac myxoma was 
discussed. (Folia Morphol 2014; 73, 3: 374–382)
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INTRODUCTION
Cardiac myxomas (CMs) are the most common 
primary heart tumours in adults, accounting for 50% 
of the cases [65]. Diverse clinical manifestations and 
malignant behaviours of this benign neoplasm have 
attracted considerable interest [33]. Multipotential 
undifferentiated mesenchymal cells are believed to 
be the origin of CM [30]. Instant studies revealed that 
CMs are neoplastic rather than thrombogenic in ori-
gin, as mesenchymal cells represent divergent diffe-
rentiations [1, 14]. Pathological changes representing 
differentiations, such as chondrification, calcification, 
ossification, extramedullary haematopoiesis, thymic 
remnants and mucin-producing glands occasionally 
found in CM, indicating a neoplastic origin arising 
from foregut remnants [76]. Immunohistochemical 
evidences of indifferentiated mesenchymal cells, non-
-metastatic nature in most cases [16], gland-like, 
epithelium-lined cystic and tubular spaces with fea-
tures of the mesothelioma [22], and ultrastructurally 
proved active secretional structures [21, 23, 32] also 
supported the neoplastic origin theory. Neverthe-
less, the organising cardiac intramural thrombi and 
papillary endocardial lesions of histological featu-
res similar to those of CM challenged the neoplastic 
origin hypothesis [64], and the exact origin of CM 
still remains disputable [3]. Furthermore, histology, 
histochemistry and immunohistochemistry of CM 
have been sufficiently studied; whereas pertinent 
aspects of glandular CM have not, due to the rarity 
of the glandular differentiation. As estimated in the 
literature, glandular CM are rare representing about 
5% of CM [38]. The aim of this article is to present 
the structural and immunohistochemical features of 
glandular CM by a case report with literature review, 
and to further discuss the origin of CM.
CASE REPORT
A 51-year-old female had abrupt vision loss 
6 months prior to current admission. She was then 
referred to a nearby hospital and was diagnosed with 
“top of the basilar” syndrome and cardiogenic shock 
caused by a left atrial myxoma. She also developed 
multiple arterial embolisms of her lower extremities 
involving bilateral anterior tibial, bilateral posterior 
tibial, right popliteal and bilateral dorsal arteries as 
evidenced by ultrasonography. Her condition was 
gradually stabilising after prolonged treatment. She 
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was recently referred to this hospital for surgical 
treatment of left atrial myxoma. After admission, 
the diagnosis of left atrial myxoma was confirmed 
by echocardiography and chest computed tomogra-
phy. Her vital signs were normal. Precordial systolic 
murmurs were only audible in a sitting position on 
the 5th morning after admission. She was conscious 
but apathy, with bilateral blepharoptoses and poor 
pupillary light reactions. Her left pupil was 4 mm 
and right pupil was 2 mm in diameter. She showed 
poorly upward, downward and adducted eye move-
ments, and slightly decreased right lower limb muscle 
strength but symmetrical deep tendon reflexes.
Left atrial myxoma resection was performed under 
cardiopulmonary bypass. During the operation, the 
myxoma was found to be originated from the free 
wall of the left atrium. The myxoma was resected en 
bloc, and the iatrogenic atrial wall defect was repai-
red with an autologous pericardial patch. She had 
a delayed aesthetic awakening until postoperative 
hour 13.5 with no new neurological sequelea. She 
had an uneventful postoperative course and was 
discharged home on postoperative day 19.
The myxoma was grossly villous, polypoid, and 
loosely lobulated with smooth, glistening surface, 
measuring 4.5 × 4.5 × 3.0 cm in size (Fig. 1). The 
myxoma was brown in colour, uncapsulated and 
broadbased without a pedicle. On the cut surface, 
the myxoma was gelatinous and semitransparent with 
partially haemorrhagic and cystic regions. Microsco-
pically, the myxoma was composed predominantly 
of scattered stellate, spindle-shaped, or polygonal 
myxoma cells, with small endothelial vascular chan-
nels lying in a loose myxoid stroma.
Glandular structures were focally located at the 
base of the myxoma dispersed in the loose amorphous 
stroma (Fig. 2). Some glands had obvious lumina, whi-
le others did not. Gland fusions were noted (Fig. 3). 
In overall, the glandular structures were well-develo-
ped by irregularly arranged single columnar, cuboid, 
or flat cells. There were a few goblet cells with cyto-
plasmic mucin vacuoles. No obvious atypia, mitosis, 
or necrosis was present.
The immunohistochemical stains utilised the 
antibodies against pan-cytokeratin (CK) (AE1/AE3), 
vimentin, CK7, CK20, epithelial membrane antigen 
(EMA), smooth muscle actin (SMA), Ki-67, Factor VIII, 
desmin, S100, oestrogen receptor, c-erbB2, B-cell 
lymphoma 2 (Bcl-2), myogenin, melanoma marker 
HMB45, cellular tumour antigen p53, lambda light 
chain, CD3, CD20, CD34, CD56, CD57, CD68, CD79a, 
CD99, CD138, proliferating cell nuclear antigen and 
Figure 1. Gross appearance of the myxoma, which was grossly 
villous, polypoid.
Figure 2. Glandular structures were focally located at the base of 
the myxoma; HE × 25.
Figure 3. Gland fusions (arrows); HE × 400.
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cyclin D. The glandular structures were strongly and 
diffusely immunoreactive to vimentin (Fig. 4) and 
EMA (Fig. 5), moderately to carcinoembryonic an-
tigen (CEA) (endothelium-lined area) (Fig. 6) and 
CD34 (glandular epithelium) (Fig. 7) and weakly and 
scatteredly immunoreactive to CD3 (Fig. 8), CD20 (Fig. 9) 
and Ki-67 (Fig. 10), but negatively immunoreactive 
to SMA, Factor VIII, pan-CK, desmin, S100, oestrogen 
receptor, c-erbB2, Bcl-2, myogenin, HMB45, P53, lam-
bda light chain, CD56, CD57, CD68, CD79a, CD99, 
CD138, proliferating cell nuclear antigen and cyclin D.
DISCUSSION
A comprehensive literature collection of glan-
dular CM was made in PubMed, Google and Baidu 
search engines, Highwire Press, Airitilibrary, LILACs, 
sinomed.imicams.ac.cn/jp/ and Chinese Medical 
Citation Index (CMCI). The search terms included 
“heart myxoma”, “cardiac myxoma”, “atrial myxo-
ma”, “valvular myxoma”, “glandular component”, 
“glandular structure” and “gland-like structure”, and 
the search ended on December 31, 2013. A total of 
124 reports were collected including 108 (e-)journal 
articles, 9 book chapters and 9 web pages. Of them, 
54 reports describing CM without any glandular 
components, or narrating glandular differentiation 
of CM without patient information, such as review 
articles, book chapters and majority of the web pa-
ges, were excluded from the statistical analysis of 
this study. Alternative exclusion criteria included du-
plicate publications [20, 26, 28, 46, 48], and original 
articles with only patient number [2, 9, 35], or even 
Figure 4. Immunohistochemical expression of vimentin in glandular 
structures; En Vision × 400. 
Figure 5. Immunohistochemical expression of epithelial membrane 
antigen in glandular structures; En Vision × 400.
Figure 6. Immunohistochemical expression of carcinoembryonic 
antigen in glandular structures; En Vision × 400.
Figure 7. Immunohistochemical expression of CD34 in glandular 
structures; En Vision × 400.
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with no patient number [7, 13, 66, 80] of glandular 
CM without patient information, with 3 intracardiac 
heterotopia of epithelium [6, 11, 51], and describing 
a bone metastasis of glandular CM, however, the in 
situ CM did not show any glandular components [69]. 
Finally, 54 reports (30 case reports [4, 5, 8, 16, 17, 22, 
24, 27, 34, 36–41, 43–45, 52, 53, 55, 58, 62, 63, 65, 
66, 68, 70, 74, 77], 23 original articles [10, 12, 14, 15, 
19, 21, 29, 30, 47, 54, 56, 59–61, 64, 67, 72, 73, 75, 
78, 79, 81, 82] and 1 case series [18]) were included, 
with 99 patients with a glandular CM (a total of 100 ca- 
ses including the present patient) representing 
7.4% of the 1,351 CM patients under investigation. 
Of the 100 patients, 24 were males and 39 were 
females with a male-to-female ratio of 1:1.63, while 
gender could not be tracked in 37 patients. Their age 
was 51.2 ± 16.4 (range 10–78; median 53.5) years 
(n = 40). There was no age difference between male 
and female patients (51.4 ± 17.3 years vs. 51.0 ± 16.1 
years, p = 0.9386). Of the developmental patterns, 
24 (80%) were sporadic and 6 (20%) were familial 
(c2 = 0.0000, p = 1.0000). Locations of the CM were 
described in 65 patients: 46 (70.8%) in the left atrium, 
16 (24.6%) in the right atrium and 3 (4.6%) in both 
atria (c2 = 67.3, p = 0.0000). The dimensions of the 
myxomas were 5.9 ± 2.0 (range 2.8–9; median 4.8) 
cm (n = 30). The left atrial myxoma measured 4.9 ± 1.7 
(range 1.5–7.8; median 4.5) cm (n = 17) [1, 15, 17, 
18, 24, 27, 34, 36–38, 44, 45, 53, 62, 68, 73], and 
the right atrial myxomas extended 7.6 ± 3.5 (range 
2.5-16; median 7.1) cm (n = 10) [4, 5, 8, 12, 18, 22, 
24, 39–41, 58]. The dimensions of the right atrial 
myxomas were much larger than that of the left 
(p = 0.0112). The weight of the myxoma was repor-
ted in 5 patients which was 41.2 ± 38.7 (range 5–109; 
median 37.5) g (n = 6) [18, 22, 44, 65, 68] (1 patient 
had biatrial myxomas weighed). The myxomas were 
pedicled in 9 patients [1, 22, 24, 34, 36, 37, 40, 68, 
73], of whom 4 patients had their pedicles measured 
with a length of 1.5 ± 1.1 (range 0.3–3.0; median 1.3) 
cm (n = 4); whereas 4 myxomas were broad-based 
[8, 24, 39, 44]. The attachment site of the myxomas 
was described in 40 patients, with atrial septum (fossa 
ovalis) being the most common attached site (Fig. 11). 
The locations of the glandular structures were re-
ported in 41 cases: 37 (90.2%) were at the base 
[1, 8, 30, 37, 40, 44, 56, 60, 65, 73, 75, 79], 2 (5.4%) 
scattered [36, 60], 1 (2.4%) central [72] and 1 (2.4%) 
central and at the base of pedicle [39]. The distribu-
tions of the glandular structures were expressed in 
Figure 8. Weak and scattered immunoreaction to CD3 in glandular 
structures; En Vision × 400.
Figure 9. Weak and scattered immunoreaction to CD20 in glandu-
lar structures; En Vision × 400.
Figure 10. Expression of Ki-67 was only less than 1% in glandular 
structures; En Vision × 400.
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52 patients: 21 (40.4%) were focal [4, 8, 12, 17, 19, 
22, 24, 44, 45, 52, 58, 59, 62, 72, 73], 16 (30.8%) 
were prominent [10, 14, 18, 30, 36, 37, 40, 43, 47, 
53, 60, 77, 82], 11 (21.2%) were scattered [5, 10, 
21, 47, 60, 68, 79], and 4 (7.7%) were widespread/ 
/extensive [15, 24, 48, 64]. Development of the glan-
dular structures were given in 28 patients: 25 (83.3%) 
were well-developed [8, 12, 14, 17, 21, 24, 27, 36, 
38, 40, 43, 53, 64, 65, 73, 75, 79], 1 (3.3%) was very 
poorly formed [65], 2 (6.7%) had variable structures 
[22, 56] and 2 (6.7%) were pseudo-glands [34, 54]. 
In 1 patient, the glandular CM formed by irregular, 
angulated contours with cribriform architectures [17]. 
A CM of another patient showed confluent glandular 
structures [38]. The present patient had irregular, not 
very well developed glands, and confluences of glands 
were seen as well. Mild focal nuclear atypia [1, 65, 
73, 81] and occasional atypical mitosis [1, 17, 68, 
81] were reported in 4 (4%) patients, each. Besides, 
epithelial cells with an abrupt transition into myxo-
ma cells were observed in 3 patients [14]. Malignant 
transformation of glandular structures in a CM was 
observed in 3 (3%) cases [8, 43, 52].
Histologically, typical myxoma cells are mode-
rate amount of stellate or spindle-shaped myxoma 
cells, eosinophilic cytoplasm, occasional perivascular 
aggregates, bubbly to fibrillar stroma with focal hae-
morrhage, fibrin insudation and haemosiderin-laden 
macrophages, and absence of nuclear atypia, mitosis, 
or necrosis [14, 22]. Some of these glands contained 
luminal mucin [14]. Haemorrhagic areas, haemosiderin 
laden macrophages, neutrophil, leukocytes and lymp-
hocytes were also observed in myxoid stroma [62].
Immunohistochemical studies of CMs are in 
3 ways: surface lining cells, stromal myxoma cells and 
perivascular cells [17]. Myxoma cells were positively 
reactive to Factor VIII (focal, endothelium-lined area), 
SMA [1] and vimentin [1, 8, 37], which was observed 
in spindle cells of the stroma [36], neuron-specific 
enolase (NSE) (slightly and focally) [8, 36], S100 (a 
few dendric cells) [8, 37] and SMA (slightly and focally, 
sparse muscular areas) [36], and those with some 
muscle fibres [37]; but negative to CK, EMA, CEA, 
Leu 1 and desmin [1]. Negative reaction was also 
noted in staining with Factor VIII [36]. Matrix showed 
positivity to vimentin (spindle cells of the stroma) 
[36], vimentin [38, 40], calretinin [38, 40]; negative 
to Factor VIII [36], CEA [40], S100 [40], CK [40], CK7 
[40] and CK20 [40]. Endothelium-lined capillaries 
of myxomas were positive to ulex europaeus [14], 
vimentin (stellate cells) [40], SMA [36], Factor VIII 
[36, 38], vimentin [37], CD31 [38], CD34 [38], S100 
(occasional stellate cells) [40] and CEA (focally, stellate 
cells) [40]; but negative also to CEA [40], CK [40], CK7 
[40] and CK20 [40]. The expressions of pan-CK and 
CEA are in keeping with the epithelial differentiation 
in CM. The myxoma cells were positive for SMA, 
but negative for desmin and S100, and therefore 
myofibroblastic cells were suggested as the cell of 
origin [3]. Myxoma cells were positive for calretinin 
in 75–100% of cases, but had variable positivity for 
Figure 11. Distribution of attachment sites of the myxomas in (A) 
overall, and (B) left atrium; IAS — intraatrial septum; LA — left 
atrium; MV — mitral valve; RA — right atrium.
A 
B
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vimentin, a1-antichymotrypsin, a1-antitrypsin, S100, 
SMA, desmin, synaptophysin, NSE and endothelial 
markers; only epithelioid structures may be positive 
for epithelial markers (pan-CK, CAM5.2, CK34E12, 
CK7, CK20, EMA and CEA) [9].
CM showed two patterns of glandular structures: 
glands separated from myxoma cell islands are termed 
as Pattern 1, and glands within the myxoma cell islands 
are termed as Pattern 2 [47]. Glandular structures were 
predominantly present at the base or the pedicle of 
the CM [1, 14]. The well-developed glandular spaces 
were lined by a single layer of cuboidal to tall colum-
nar cells, with the presence of scattered goblet cells 
[79], surrounded by amorphous extracellular myxoid 
material [41]. In 5.56% (3/66), additional glandular and 
pseudocystic elements were found. The proteoglycan-
-rich myxoid and vascularised stroma also contained 
dendritic cells, macrophages and scattered lymphocy-
tes [61]. The cyst-like spaces are lined by epithelium-like 
cells, from tiny gland-like structures to the larger cystic 
spaces [5]. Basal membrane or cilia can be absent in 
the glands [1]. Regular, columnar goblet cells indicate 
well-developed glandular structures [36]. In addition 
to cells with intracellular lumina, there are some gob-
let or signet ring cells with bluish cytoplasmic mucin 
vacuoles [38].
Secretory epithelium dispersed in a myxoid mu-
cinous stroma may lead to a misdiagnosis as a very 
well-differentiated mucin secreting adenocarcinoma 
[43]. Glands may be composed of cells with irregular 
hyperchromatic nuclei of various size and shape and 
distinct large nucleoli indicating the potential trans-
ferrable and differentiating capacities of CM [17]. 
Focal stratification, tuft formations and micropapilae 
were seen in the glandular structures [1]. Rupture 
of glands into the stroma [22], apparent transition 
from flattened and spindled myxoma cells to plump 
glandular cells [22], transition from typical myxoma 
cells to cord-like myxoma cells [60], paradoxical trans-
ition from epithelial cells to myxoma cells [14] and 
direct links between glands and perivascular myxoma 
cells [60] were also observed. Small areas of benign 
glands in close contact with the adenocarcinoma and 
metastases to the lung, kidney, left adrenal gland and 
bones were reported [20].
The glandular epithelium has been histochemically 
and immunohistochemically identified a gastrointe-
stinal or enteric nature of the epithelium. Periodic 
acid Schiff (PAS)-positive cytoplasmic globules and 
strong immunoreactivity against cytokeratin were de-
monstrated in the cuboidal and low columnar simple 
epithelium [12]. PAS and Alcian blue (AB) stainings 
were positive in 3 places of glandular structures of 
myxoma: the gland lumina, the goblet cells and the 
brush border, where mucus was generated [38]. Ba-
sal positivity for PAS and apical positivity for AB and 
mucicarmine were noted [40].
Immunohistochemically some endothelial mar-
kers, such as CD31, CD34 and Factor VIII, are present 
in myxoma cells. Positive staining has also been re-
ported for S100, calretinin, vimentin, desmin, smooth 
muscle myosin, CD56, a1-antitrypsin and a1-antichy-
motrypsin [25], and interleukin-6 [27]. Willebrand 
factor was only detected in endothelial cells lining 
vascular channels and deep invaginations of surface 
papillae [53].
Glandular structures showed positive reactions 
to CK (50%), EMA (focal, luminal), CEA (50%), Leu 1; 
Ulex europaeus (epithelial cells and erythrocytes) [1], 
CK (glandular epithelium) [36, 40, 43], CEA 
(apical surface cytoplasm) [36, 38, 40], pan-CK 
[38], CD31 (focal) [38], S100 (focal glands) [40], 
calretinin [40], CK7 [38, 40], vimentin (cytoplasm) 
[40], CA19.9 (cytoplasmic membranes, mainly at 
the apical side and intracytoplasmic vacuoles) [36], 
mesothelioma marker HBME-1 (focal) [38] and in-
terleukin-8 [27]; while negative to Factor VIII [14], 
NSE (cytoplasm, slightly) [36], pan-CK [37], CK20 
[38, 40], calretinin [38], CEA [37], CD68 [37] and 
chromogranin A [36, 37]. The histopathology of 
the present case was compatible with the current 
literature. 
Positivity to CEA is a characteristic of endoder-
mal origin, indicating that the myxoma cells are of 
capacities of the endoderm cells [29]. The satellite 
cells express simultaneously S100 and synaptop-
hysin (Syn), suggesting the origin of myxoma may 
be associated with the endocardial sensory nerve 
tissue [13]. The staining of CK reactivity was ob-
served mostly in the surface lining cells [19]. In the 
case with glandular differentiation, the positivity 
was both within the glandular component and the 
surrounding myxoma cells [17]. Vimentin, EMA, 
pan-CK, CK7, CEA and calretinin were positive in 
the glandular structures and variably in stellate 
cells and blood vessels [40]. Pan-CK and CK7 were 
strongly positive along with EMA and CEA, where-
as CK20 was negative in the glandular structures, 
indicating a possibility of entrapped foregut rest 
origin of CM [40].
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p53 protein immunoreactivity could be an indica-
tor for discrimination between neoplastic and reactive 
mesothelium [49]. Generally, the regular glandular 
structures showed rare nuclear p53 staining. Foregut 
remnants, bronchial or alveolar epithelium, mesothe-
lium and germ cells have been supposed as the origin 
of the glandular structures. Uncommon proliferative 
activity was considered “reactive” atypia, in the CM 
with glandular differentiation, the mitotic index and 
degree of atypia, with striking variation in size and 
shape of nuclei were more likely an early malignant 
behaviour than reactive process [17]. Ki-67 repre-
sents the proliferation rate, and studies of CM on this 
aspect revealed a slow proliferative rate [50]. Pucci et 
al. [48] reported that a very low proliferative activity 
(< 2%) was detected in glandular cells of case 3 by 
means of Ki-67 immunoreactivity. Berger et al. [8] 
noted that the proliferation rate with Ki-67 was less 
than 10% in the benign glands of CM and about 80% 
in the malignant glands of the adenocarcinoma and 
the systemic metastases.
The myxoma cells bear some similarities with me-
sothelial cells [38]. Expressions of both epithelial and 
vascular antigens reflect the multipotential nature of 
myxoma cells. Heterotopia in CM provides evidence to 
the theory of a pluripotent reserve cell line of origin 
arising from embryonic rests [42]. Differential diag-
noses of CM include intracardiac thrombus, cardiac 
excrescence and other primary or metastatic cardiac 
neoplasms [9]. Immunohistochemical study can meet 
the satisfaction of the differential diagnosis [9]. Glan-
dular CM have to be distinguished from a metastatic 
carcinoma as small areas of benign glands resemble 
adenocarcinoma [20, 46]. Nevertheless, atypia and 
mitosis are rarely present in the former [71]. CM, renal 
angiofibrolipomas and thyroid adenoma presented 
considerable atypism at the same time, and therefore 
CM may be in accord with the hamartoma in view of 
histogenesis [31]. Side-by-side malignant and benign 
glands could be detected in the small transitional 
zone between myxoma and adenocarcinoma, indica-
ting transferable capacities of the myxoma cells [8].
CONCLUSIONS
Glandular CMs are morphologically characterised 
by base locations, focal distributions and well-deve-
loped structures in most cases with low proliferative 
and metastatic natures. They might derive from en-
trapped embryonal rests of a precursor cell toward 
epithelial and mesenchymal lineages. Differentiated 
glandular structures present in CM cells, other than 
in the thrombus, support the neoplastic origin of CM. 
Well-developed glands with basement membranes, 
junctional complexes and apical secretory granules 
revealed by ultrastructural studies also support the 
neoplastic origin of CM.
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